Lilly and Boehringer Ingelheim will now be able to promote their drug Jardiance in the US as a way for diabetes patients ... death risk by 38%. An oral SGLT2 inhibitor, Jardiance (empagliflozin ...

was approved in January 2020 as the only triple combination oral therapy for type 2 diabetes. Trijardy combines Jardiance, ...

Eli Lilly and Boehringer Ingelheim have changed the terms of their diabetes alliance to focus their energies on developing their big-selling Jardiance pill. Under the terms of the original ...

Rybelsus comes as an oral tablet ... Ozempic compare with metformin and Jardiance. Approved uses to help manage blood sugar levels in adults with type 2 diabetes • to help manage blood sugar ...

A new study, published in JAMA Neurology, finds that people with type 2 diabetes who take two common anti-diabetes medications had a reduced risk of Alzheimer’s and associated dementias.

Image credit: mbbirdy/Getty Images. A new study investigates the relationship between specific diabetes drugs and dementia. They used data from more than 92,000 people with type 2 diabetes.